Sana Biotechnology Inc vs VanEck Vietnam ETF — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while VanEck Vietnam ETF trades at $16.92. The key difference: VanEck Vietnam ETF is trading nearer its 52-week high, Sana Biotechnology Inc nearer its low. Which is the better fit depends on your goals.
| SANA | VNM | |
|---|---|---|
Market Cap | $873.84M | — |
Sector | Health | Sector/Thematic |
52-Week High | $5.92 | $19.80 |
52-Week Low | $2.68 | $15.35 |
Enterprise Value | $848.03M | — |
Trailing returns across standard periods
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →VNM is the first and largest U.S.-listed ETF providing targeted exposure to the Vietnamese equity market. It tracks the MarketVector™ Vietnam Local Index, which includes publicly traded companies that are locally incorporated in Vietnam. It serves as a liquid, transparent vehicle for investors looking to participate in Vietnam's transition into a global manufacturing hub and its long-term potential for emerging market reclassification.
Read more on VNM →